Other Guidelines | Page 37 | European Cystic Fibrosis Society (ECFS)

The influence of cystic fibrosis on work ability of affected patients

Clofazimine use for treatment of mycobacteria in children with and without cystic fibrosis

Stopping exposure to smoke improves breathing and nutritional outcomes in children and adolescents with cystic fibrosis

Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis

Do bone active therapy and lung disease influence the skeletal outcome after transplantation?

Using an Antibiotic Treatment Called Amikacin Liposome Inhalation Suspension (or ALIS) for Chronic Infection With Pseudomonas aeruginosa in People With Cystic Fibrosis for 2 years

Orkambi may improve liver disease in people with CF

Review of pregnancy in cystic fibrosis

Is elexacaftor/tezacaftor/ivacaftor always better than ezacaftor/ivacaftor?

CF Pancreatic Duct Secretions Can Alter Islet Function

first
previous
…
33
34
35
36
37
38
39
40
41
…
next
last